Beginning Cash: The amount of cash reported by the company on its previous statement.
Sernova Biotherapeutics Inc. (SEOVF) had Beginning Cash of $0.19M for the most recently reported fiscal quarter, ending 2026-07-31.
| Income Statement Financials | |
-- |
|
$-1.81M |
|
-- |
|
-- |
|
$1.52M |
|
$-1.52M |
|
$-0.33M |
|
$-1.84M |
|
$-1.84M |
|
$-1.81M |
|
$-1.81M |
|
$-1.81M |
|
$-1.81M |
|
$-1.52M |
|
$-1.51M |
|
377.64M |
|
377.64M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.26M |
|
$0.00M |
|
$0.00M |
|
$0.27M |
|
$8.63M |
|
$0.06M |
|
$0.06M |
|
$8.69M |
|
$-17.03M |
|
$-8.42M |
|
$-8.42M |
|
377.64M |
|
| Cash Flow Statement Financials | |
$-3.04M |
|
-- |
|
$2.90M |
|
|
Beginning Cash |
$0.19M |
$0.05M |
|
$-0.14M |
|
$1.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-0.01 |
|
-0.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
10.64% |
|
21.52% |
|
-676.25% |
|
21.66% |
|
$-0.02 |
|
$-0.01 |
|
$-0.01 |
|